Annual General Shareholders’ Meeting 2023 – June 16, 2023 - 2nd call – Expected to be held on this date / June 15, 2023 - 1st call. Click here.

Close
Skip to content
Search
 
Search
EN  
  • ES
  • DE
  • ZH
   
  • Company
  • Innovation
  • Sustainability
  • Products and services
  • Investors
  • Careers
  • Media
  • Partners
  • Contact
 

Company

Since 1909, Grifols has worked to improve the health and well-being of people around the world.

Read more

  • What we do
    • Biopharma
      • From donors to patients
      • Plasma journey
    • Diagnostic
    • Bio Supplies
    • Healthcare Solutions for Hospitals
  • Mission and values
  • Ethics and compliance
  • Grifols Engineering
    • Engineering
      • Project Management
      • Biotech Processes
      • General Processes
    • Machinery
      • Tailor-made Solutions
      • Pharmaceutical Robotics
      • Standardized Processes
    • Consulting
    • Contact
  • Our history
  • Grifols museum
    • La Casa: where it all began
    • The Plant: people helping people
    • The World: From family business to global company
  • Grifology
    • The Cabinet

Every action we take is motivated by our mission to improve people's lives.

Read more

Our unique and remarkable history combines scientific expertise with a desire to serve patients and society.

Read more

We develop, produce and market innovative medicines, solutions and services in more than 110 countries.

Read more

 

Innovation

Grifols is full speed ahead on developing the next innovative breakthroughs across multiple therapeutic areas.  

Read more

  • Plasma Powerhouse
  • Beyond plasma
  • Key therapeutic areas
    • Immunology
    • Hepatology and Intensive Care
    • Pulmonology
    • Hematology
    • Neurology
      • AMBAR®: Research in Alzheimer's Disease
      • AMBAR® Clinical program
    • Infectious Diseases
    • Further Therapeutic Opportunities
  • Extending our innovative reach
    • Team up with Grifols Innovation and New Technologies
    • Scientific Awards and Programs
  • Connecting knowledge - Our R&D network

We apply our growing knowledge of plasma to change healthcare.

Read more

Our treatments are enhancing people’s well-being and quality of life.

Read more

We’re drawing on a broad scientific base to continue innovating.

Read more

 

Sustainability

Grifols' longstanding commitment to people and the planet entails helping society on all fronts.

Read more

  • Commitment to donors and patients
    • Supporting donors
    • Supporting patients
  • Impact on society
  • Our people
  • The environment
  • Ethical leadership
  • Sustainability Reports

2022 Sustainability Report: a detailed overview of our sustainability strategy, actions and progress

Read

Patients drive the work we do every day. We support patients and patient associations.

Learn more

As mindful stewards of the environment we are resolved to fight climate change.

Read more

 
 

Investors

Read more

  • Stock information
    • Stock and share capital
    • Dividends
    • Major holders and treasury stock
    • Agreements between shareholders
    • Analyst coverage
  • Financials
    • Financial results
    • Annual accounts
    • Fixed income and credit ratings
    • Average period of payment to suppliers
  • Press releases
  • Presentations and events
  • Agenda
  • Communications with regulators (CNMV/SEC)
    • CNMV
    • SEC
    • Other relevant information
    • Inside information
    • Relevant events up to Dec. 31st, 2019
  • Corporate Stewardship Reports
  • Corporate governance
    • Board of Directors
      • Committees
      • Regulations
    • General Shareholders’ Meeting
    • Annual corporate governance report
    • Directors' remuneration report
    • Articles of association
    • Corporate policies
  • Mergers
  • Biotest: voluntary takeover offer |
    Freiwilliges übernahmeangebot

Here you can read our Q1 2023 financial results

Read results

Please click here to listen to the webcast of our Q1 2023 financial results

Listen to the webcast

The 2022 Integrated and Sustainability Annual Report is now available

Read more

 

Careers

People are at the heart of our business. We are committed to continued investment in training and development.

Read more

  • Training and development
 

Media

Latest news about the company and contact information for journalists and communication professionals.

Read more

  • Media contacts
  • Newsroom
  • Media Center
 
 

Contact

Read more

  • International Headquarters
  • Adverse reactions – Pharmacovigilance
  • Grifols Ethics Helpline
Search
Show menu
   
Search
com.grifols.labels.close-menu
Company   Innovation   Sustainability   Products and services Investors   Careers   Media   Partners Contact  
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Company What we do   Mission and values Ethics and compliance Grifols Engineering   Our history Grifols museum   Grifology  
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
What we do Biopharma Diagnostic Bio Supplies Healthcare Solutions for Hospitals
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Mission and values
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Ethics and compliance
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Grifols Engineering Engineering Machinery Consulting Contact
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Our history
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Grifols museum La Casa: where it all began The Plant: people helping people The World: From family business to global company
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Grifology The Cabinet
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Innovation Plasma Powerhouse Beyond plasma Key therapeutic areas   Extending our innovative reach   Connecting knowledge - Our R&D network
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Plasma Powerhouse
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Beyond plasma
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Key therapeutic areas Immunology Hepatology and Intensive Care Pulmonology Hematology Neurology Infectious Diseases Further Therapeutic Opportunities
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Extending our innovative reach Team up with Grifols Innovation and New Technologies Scientific Awards and Programs
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Connecting knowledge - Our R&D network
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Sustainability Commitment to donors and patients   Impact on society   Our people The environment Ethical leadership Sustainability Reports
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Commitment to donors and patients Supporting donors Supporting patients
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Impact on society
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Our people
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
The environment
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Ethical leadership
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Sustainability Reports
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Products and services
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Investors Stock information   Financials   Press releases Presentations and events Agenda Communications with regulators (CNMV/SEC)   Corporate Stewardship Reports Corporate governance   Mergers Biotest: voluntary takeover offer |
Freiwilliges übernahmeangebot  
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Stock information Stock and share capital Dividends Major holders and treasury stock Agreements between shareholders Analyst coverage
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Financials Financial results Annual accounts Fixed income and credit ratings Average period of payment to suppliers
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Press releases
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Presentations and events
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Agenda
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Communications with regulators (CNMV/SEC) CNMV SEC Other relevant information Inside information Relevant events up to Dec. 31st, 2019
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Corporate Stewardship Reports
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Corporate governance Board of Directors General Shareholders’ Meeting Annual corporate governance report Directors' remuneration report Articles of association Corporate policies
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Mergers
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Biotest: voluntary takeover offer |
Freiwilliges übernahmeangebot
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Careers Training and development
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Training and development
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Media Media contacts Newsroom Media Center  
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Media contacts
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Newsroom
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Media Center
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Partners
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Contact International Headquarters Adverse reactions – Pharmacovigilance Grifols Ethics Helpline
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
International Headquarters
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Adverse reactions – Pharmacovigilance
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Grifols Ethics Helpline
English  
  • Spanish
  • German
  • Chinese

Follow

NEWSROOM

 

179 results have been found

  • Company statement
  • Press release
  • Corporate
  • Investors
  • Products
  • Sustainability
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

Order by: Newest A-Z

June 8, 2023

Grifols Group enters into agreement with Canadian Plasma Resources to secure plasma supply in Canada

Read Release

June 7, 2023

Grifols Egypt delivers first plasma medicines made from Egyptian plasma donations

Read Release

May 11, 2023

Grifols launches AlphaID™ At Home, enabling U.S. consumers to self-screen for genetic COPD

Read Release

May 9, 2023

Grifols delivers strong first quarter financials with 23% revenue growth and an Adjusted EBITDA margin above guidance of 21%

Read Release

May 8, 2023

Grifols realigns management structure to accelerate company performance and simplify its corporate governance

Read Release

View More

Choose country
DISCLAIMER_CONTENT
Cancel

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed to, promoting any products in countries in which they are not approved.

Follow

© 2023 Grifols, S.A. All rights reserved worldwide.

ABOUT US

Company

Sustainability

Innovation

Products & services

Investors

Careers

Media

TOP WEBSITES

Grifols Plasma

The Grifols Academy of Plasmapheresis

Grifols Scientific Awards

Grifols Engineering

Grifols Egypt for Plasma Derivatives

Victor Grifols i Lucas Foundation

Probitas Foundation

J.A. Grifols Foundation

HELP

Privacy notices

Cookies policy

Cookie Settings

Terms of use

Contact

Glossary

© 2023 Grifols, S.A. All rights reserved worldwide.

 

This website uses its own and third party essential (to remember your settings) and non-essential (to analyse our traffic) cookies. Further information about our use of cookies and the third parties using them can be found in our Cookies Policy.

You can accept all non-essential cookies by clicking the "Accept" button, reject their use by clicking the "Refuse" button or set your preferencies by clicking the "Settings" link.

You can withdraw or change your cookies consent at any time by visiting our Cookies Policy.

Settings

Refuse Accept
 
Close

Grifols, S.A.

Avenida de la Generalitat, 152, 08174

Sant Cugat del Vallès (Barcelona), Spain

Essential cookies

These are strictly necessary for the Site to work as requested. Some examples are activating basic functions such as page navigation and access to secure Site areas or customizing the Site presentation (e.g. language). Without these cookies, the Site would not be able to work properly.

Cookies details

By clicking below you consent to the use of the following non-essential cookies:

Analytic cookies

These allow understanding how visitors interact with the Site by monitoring and analyzing your behavior and with the purpose of improving the Site.

Cookies details

Save settings